Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

APhA

This article was originally published in The Tan Sheet

Executive Summary

House of Delegates approves position policies on dietary supplement regulation at March annual meeting. The group advocates: increased FDA influence over the marketing of supplements; supplement labeling that includes ingredients, ingredient sources and strengths, and population-specific usage directions; adoption of "clear and effective enforcement policies"; creation of an FDA database of AERs; the establishment of GMPs; and industry-wide observance of USP/NF standards. Additionally, APhA will enlist health care professionals for consumer outreach programs. An action plan is expected to win board approval in May
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091051

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel